It is still unclear whether the elevated levels of apelin seen in obesity are an attempt to overcome insulin resistance, obesity-related cardiovascular diseases, or another metabolic defect like apelin resistance, despite apelin being thought of as a beneficial adipokine that is upregulated in obesity. The gene discussed is APLN; the disease is cardiovascular disorder.